These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37205263)

  • 1. Competing Heterogeneities in Vaccine Effectiveness Estimation.
    Nikas A; Ahmed H; Zarnitsyna VI
    ArXiv; 2023 May; ():. PubMed ID: 37205263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competing Heterogeneities in Vaccine Effectiveness Estimation.
    Nikas A; Ahmed H; Zarnitsyna VI
    Vaccines (Basel); 2023 Aug; 11(8):. PubMed ID: 37631880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Waning of Measured Influenza Vaccine Effectiveness Over Time: The Potential Contribution of Leaky Vaccine Effect.
    Tokars JI; Patel MM; Foppa IM; Reed C; Fry AM; Ferdinands JM
    Clin Infect Dis; 2020 Dec; 71(10):e633-e641. PubMed ID: 32227109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating Waning of Vaccine Effectiveness: A Simulation Study.
    Nikas A; Ahmed H; Zarnitsyna VI
    Clin Infect Dis; 2023 Feb; 76(3):479-486. PubMed ID: 36056892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological heterogeneity informs estimation of the durability of vaccine protection.
    Domenech de Cellès M; Wong A; Andrea Barrero Guevara L; Rohani P
    J R Soc Interface; 2022 May; 19(190):20220070. PubMed ID: 35611620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of waning vaccine effectiveness from population-level surveillance data in multi-variant epidemics.
    Murayama H; Endo A; Yonekura S
    Epidemics; 2023 Dec; 45():100726. PubMed ID: 37939501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiologic effects of varicella vaccination.
    Halloran ME
    Infect Dis Clin North Am; 1996 Sep; 10(3):631-55. PubMed ID: 8856357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depletion-of-susceptibles bias in influenza vaccine waning studies: how to ensure robust results.
    Lipsitch M; Goldstein E; Ray GT; Fireman B
    Epidemiol Infect; 2019 Nov; 147():e306. PubMed ID: 31774051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Durability of Immune Response After COVID-19 Booster Vaccination and Association With COVID-19 Omicron Infection.
    Gilboa M; Regev-Yochay G; Mandelboim M; Indenbaum V; Asraf K; Fluss R; Amit S; Mendelson E; Doolman R; Afek A; Freedman LS; Kreiss Y; Lustig Y
    JAMA Netw Open; 2022 Sep; 5(9):e2231778. PubMed ID: 36107426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interseason waning of vaccine-induced hemagglutination inhibition antibody titers and contributing factors to pre-existing humoral immunity against influenza in community-dwelling older adults 75 years and older.
    Wunderlich B; Laskow T; Li H; Zhang L; Abrams E; Tian J; Yu J; Chen Y; Tavenier J; Huang Y; Talaat K; Bream JH; Xue QL; Pawelec G; Leng SX
    Immun Ageing; 2023 Jul; 20(1):38. PubMed ID: 37525151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating vaccine coverage from serial trivariate serologic data in the presence of waning immunity.
    Wood JG; Goeyvaerts N; MacIntyre CR; Menzies RI; McIntyre PB; Hens N
    Epidemiology; 2015 May; 26(3):381-9. PubMed ID: 25764249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired immune response to vaccination against infection with human respiratory syncytial virus at advanced age.
    Guichelaar T; Hoeboer J; Widjojoatmodjo MN; Reemers SS; van Els CA; Otten R; van Remmerden Y; Boes J; Luytjes W
    J Virol; 2014 Sep; 88(17):9744-50. PubMed ID: 24920795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Projecting influenza vaccine effectiveness: A simulation study.
    Vilches TN; Shoukat A; Ferreira CP; Moghadas SM
    PLoS One; 2020; 15(11):e0241549. PubMed ID: 33141871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Waning protection after vaccination and prior infection against COVID-19-related mortality over 18 months.
    Dietler D; Kahn F; Inghammar M; Björk J
    Clin Microbiol Infect; 2023 Dec; 29(12):1573-1580. PubMed ID: 37580016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Durability of Vaccine-Induced and Natural Immunity Against COVID-19: A Narrative Review.
    Pooley N; Abdool Karim SS; Combadière B; Ooi EE; Harris RC; El Guerche Seblain C; Kisomi M; Shaikh N
    Infect Dis Ther; 2023 Feb; 12(2):367-387. PubMed ID: 36622633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A log-odds system for waning and boosting of COVID-19 vaccine effectiveness.
    Szanyi J; Wilson T; Scott N; Blakely T
    Vaccine; 2022 Jun; 40(28):3821-3824. PubMed ID: 35643564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative effect on immune response of repeated influenza vaccination and waning effectiveness in interseason for elderly people.
    Sugishita Y; Nakayama T; Sugawara T; Ohkusa Y
    Vaccine; 2020 May; 38(21):3759-3765. PubMed ID: 32276801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mathematical modelling of the waning of anti-RBD IgG SARS-CoV-2 antibody titers after a two-dose BNT162b2 mRNA vaccination.
    Cimas FJ; Torres J; Ontañón J; de Cabo C; Lozano J; Requena MÁ; Blas J; Rodríguez-García JL; Mas A; Solera J
    Front Immunol; 2023; 14():1097747. PubMed ID: 36776854
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.